Zobrazeno 1 - 10
of 6 024
pro vyhledávání: '"Central nervous system lymphoma"'
Autor:
Keiichiro Hattori, Kenichi Makishima, Sakurako Suma, Yoshiaki Abe, Yasuhito Suehara, Tatsuhiro Sakamoto, Naoki Kurita, Ryota Ishii, Ryota Matsuoka, Masahide Matsuda, Takao Tsurubuchi, Ryo Nishikawa, Shota Tanaka, Akitake Mukasa, Yoshitaka Narita, Koichi Ichimura, Motoo Nagane, Shingo Takano, Bryan J. Mathis, Eiichi Ishikawa, Daisuke Matsubara, Shigeru Chiba, Mamiko Sakata‐Yanagimoto
Publikováno v:
eJHaem, Vol 5, Iss 6, Pp 1201-1214 (2024)
Abstract Background Primary central nervous system lymphoma (PCNSL) is a rare lymphoid malignancy. Systemic profiling of the PCNSL tumor microenvironment (TME) was previously conducted through gene expression analysis. We investigated the prognostic
Externí odkaz:
https://doaj.org/article/99efe78376144072b9efa2a6c7415aaa
Autor:
Yiwen Mo, Yongjiang Li, Yuqian Huang, Mingshi Chen, Chao Zhou, Xinling Li, Yuan Wei, Ruping Li, Wei Fan, Xu Zhang
Publikováno v:
Cancer Imaging, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background The metabolic response of primary central nervous system lymphoma (PCNSL) patients has yet to be evaluated. This study aimed to assess the prognostic value of a novel scoring scale, the intracranial metabolic score (IMS), in PCNSL
Externí odkaz:
https://doaj.org/article/2ca47a5a918b4557a750f6a00a53288d
Autor:
Liwen Hu, Jianqing Tang, Xiaoli Su, Limei Zheng, Chengcong Hu, Qiulin Wu, Xuefang Lin, Saifan Zeng, Yupeng Chen, Sheng Zhang, Xingfu Wang
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract To investigate the diagnostic value of intraoperative cytology and rapid immunocytochemistry in primary central nervous system lymphoma. 254 cases of lymphoma and 82 cases of non-lymphoma were collected from 2010 to 2023. Frozen section(FS)
Externí odkaz:
https://doaj.org/article/eb2c70c0b14041debfcd72005c60532e
Publikováno v:
Biomarker Research, Vol 12, Iss 1, Pp 1-36 (2024)
Abstract The application of chimeric antigen receptor T-cell therapy in central nervous system tumors has significantly advanced; however, challenges pertaining to the blood-brain barrier, immunosuppressive microenvironment, and antigenic heterogenei
Externí odkaz:
https://doaj.org/article/60954a8e09d34cf2a8244022f988b5b1
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-8 (2024)
Abstract Objective This study aims to analyze the clinical features, Radiological findings and diagnostic characteristics (tissue biopsy, flow cytometry and cerebrospinal fluid cytology) of primary central nervous system lymphoma (PCNSL). To improve
Externí odkaz:
https://doaj.org/article/e1678116870d4795af02ebb6ab6d6629
Autor:
Marion Alcantara, Marion Chevrier, Fabrice Jardin, Anna Schmitt, Caroline Houillier, Lucie Oberic, Olivier Chinot, Franck Morschhauser, Frédéric Peyrade, Roch Houot, Khê Hoang-Xuan, Hervé Ghesquieres, Carole Soussain
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-13 (2024)
Abstract Background Results of conventional induction chemotherapies in primary central nervous system lymphoma (PCNSL) need to be improved. Ibrutinib, a BTK inhibitor, and lenalidomide, an immunomodulatory drug, have shown promising results at relap
Externí odkaz:
https://doaj.org/article/e4b9f07718ad41fb8fee30f518f61b80
Autor:
Sebastian Johannes Müller, Eya Khadhraoui, Hans Henkes, Marielle Ernst, Veit Rohde, Bawarjan Schatlo, Vesna Malinova
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract Purpose Differentiating between glioblastoma (GB) with multiple foci (mGB) and multifocal central nervous system lymphoma (mCNSL) can be challenging because these cancers share several features at first appearance on magnetic resonance imagi
Externí odkaz:
https://doaj.org/article/00c4302ef2db403ba20549b540182684
Publikováno v:
Journal of Inflammation Research, Vol Volume 17, Pp 5347-5363 (2024)
Ling Duan,1 Wenhui Guo,1 Shuo Yin,1 Shoubo Yang,1 Jie Liu,2 Yunyun Duan,3 Gehong Dong,4 Wenbin Li,1 Feng Chen1 1Department of Neuro-Oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, People’s Republic of
Externí odkaz:
https://doaj.org/article/924214d2e770493cb99bac36c84859c6
Autor:
Haoyi Li, Mingming Xiong, Ming Li, Caixia Sun, Dao Zheng, Leilei Yuan, Qian Chen, Song Lin, Zhenyu Liu, Xiaohui Ren
Publikováno v:
Cancer Medicine, Vol 13, Iss 17, Pp n/a-n/a (2024)
Abstract Background The rarity of primary central nervous system lymphoma (PCNSL) and treatment heterogeneity contributes to a lack of prognostic models for evaluating posttreatment remission. This study aimed to develop and validate radiomic‐based
Externí odkaz:
https://doaj.org/article/320b58aaae834a64a63e02f261dfe90d
Autor:
Jingjing Ma, Zhiguang Lin, Yaqi Zhang, Yun Ding, Qiming Tang, Yufeng Qian, Bo Jin, Ruben Y. Luo, Wei-Li Liao, Sheeno Thyparambil, Zhi Han, C. James Chou, James Schilling, Qing Li, Mengxue Zhang, Yunan Lin, Yan Ma, Karl G. Sylvester, Seema Nagpal, Doff B. McElhinney, Xuefeng B. Ling, Bobin Chen
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionPrimary central nervous system lymphoma (PCNSL) is a rare type of non-Hodgkin’s lymphoma that affects brain parenchyma, eyes, cerebrospinal fluid, and spinal cord. Diagnosing PCNSL can be challenging because imaging studies often show s
Externí odkaz:
https://doaj.org/article/dbd73c16b6144b0ab5b436e20370a0da